December 21, 2017 / 2:52 PM / 2 months ago

BRIEF-FDA Approves Removal Of Boxed Warning From Some Inhaled Medications

Dec 21 (Reuters) - FDA:

* FDA APPROVES REMOVAL OF BOXED WARNING FROM SOME INHALED MEDICATIONS USED TO TREAT ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

* FDA - ALERTING ABOUT NEW INFORMATION FOR CLASS OF MEDICATIONS KNOWN AS LONG-ACTING BETA AGONISTS USED IN COMBINATION WITH ICS MEDICINES TO TREAT ASTHMA

* FDA - LABELING OF MEDICINES THAT CONTAIN AN ICS AND LABA WILL RETAIN WARNING & PRECAUTION RELATED TO THE RISK OF USING LABAS WITHOUT AN ICS FOR ASTHMA Source text: [bit.ly/2kyGo7n]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below